225 related articles for article (PubMed ID: 34610306)
21. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin.
Keusekotten K; Elliott PR; Glockner L; Fiil BK; Damgaard RB; Kulathu Y; Wauer T; Hospenthal MK; Gyrd-Hansen M; Krappmann D; Hofmann K; Komander D
Cell; 2013 Jun; 153(6):1312-26. PubMed ID: 23746843
[TBL] [Abstract][Full Text] [Related]
22. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins.
Wooten MW; Geetha T; Babu JR; Seibenhener ML; Peng J; Cox N; Diaz-Meco MT; Moscat J
J Biol Chem; 2008 Mar; 283(11):6783-9. PubMed ID: 18174161
[TBL] [Abstract][Full Text] [Related]
23. TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination.
Zhu G; Herlyn M; Yang X
Nat Cell Biol; 2021 Sep; 23(9):978-991. PubMed ID: 34497368
[TBL] [Abstract][Full Text] [Related]
24. Regulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULIN.
Elliott PR; Komander D
FEBS J; 2016 Jan; 283(1):39-53. PubMed ID: 26503766
[TBL] [Abstract][Full Text] [Related]
25. The N-terminal ubiquitin-associated domain of Cezanne is crucial for its function to suppress NF-κB pathway.
Ji Y; Cao L; Zeng L; Zhang Z; Xiao Q; Guan P; Chen S; Chen Y; Wang M; Guo D
J Cell Biochem; 2018 Feb; 119(2):1979-1991. PubMed ID: 28817177
[TBL] [Abstract][Full Text] [Related]
26. LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13.
Chu Y; Kang Y; Yan C; Yang C; Zhang T; Huo H; Liu Y
Autophagy; 2021 Jul; 17(7):1684-1699. PubMed ID: 32543267
[TBL] [Abstract][Full Text] [Related]
27. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin-dependent and -independent functions of OTULIN in cell fate control and beyond.
Weinelt N; van Wijk SJL
Cell Death Differ; 2021 Feb; 28(2):493-504. PubMed ID: 33288901
[TBL] [Abstract][Full Text] [Related]
30. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.
Moquin DM; McQuade T; Chan FK
PLoS One; 2013; 8(10):e76841. PubMed ID: 24098568
[TBL] [Abstract][Full Text] [Related]
31. CYLD dysregulation in pathogenesis of sporadic inclusion body myositis.
Yamashita S; Matsuo Y; Tawara N; Hara K; Yamamoto M; Nishikami T; Kawakami K; Zhang X; Zhang Z; Doki T; Ando Y
Sci Rep; 2019 Aug; 9(1):11606. PubMed ID: 31406156
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne.
Wu X; Liu S; Sagum C; Chen J; Singh R; Chaturvedi A; Horton JR; Kashyap TR; Fushman D; Cheng X; Bedford MT; Wang B
Genes Dev; 2019 Dec; 33(23-24):1702-1717. PubMed ID: 31699778
[TBL] [Abstract][Full Text] [Related]
33. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
[TBL] [Abstract][Full Text] [Related]
34. Cylindromatosis Tumor Suppressor Protein (CYLD) Deubiquitinase is Necessary for Proper Ubiquitination and Degradation of the Epidermal Growth Factor Receptor.
Sanchez-Quiles V; Akimov V; Osinalde N; Francavilla C; Puglia M; Barrio-Hernandez I; Kratchmarova I; Olsen JV; Blagoev B
Mol Cell Proteomics; 2017 Aug; 16(8):1433-1446. PubMed ID: 28572092
[TBL] [Abstract][Full Text] [Related]
35. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of JNK signaling by the tumor suppressor CYLD.
Reiley W; Zhang M; Sun SC
J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
[TBL] [Abstract][Full Text] [Related]
37. PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.
Yang XD; Li W; Zhang S; Wu D; Jiang X; Tan R; Niu X; Wang Q; Wu X; Liu Z; Chen LF; Qin J; Su B
EMBO J; 2020 Jan; 39(2):e102201. PubMed ID: 31762063
[TBL] [Abstract][Full Text] [Related]
38. The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway.
Zhang L; Wei N; Cui Y; Hong Z; Liu X; Wang Q; Li S; Liu H; Yu H; Cai Y; Wang Q; Zhu J; Meng W; Chen Z; Wang C
PLoS Pathog; 2018 Nov; 14(11):e1007435. PubMed ID: 30388174
[TBL] [Abstract][Full Text] [Related]
39. Linear ubiquitination-mediated NF-κB regulation and its related disorders.
Tokunaga F
J Biochem; 2013 Oct; 154(4):313-23. PubMed ID: 23969028
[TBL] [Abstract][Full Text] [Related]
40. Linear ubiquitination in immunity.
Shimizu Y; Taraborrelli L; Walczak H
Immunol Rev; 2015 Jul; 266(1):190-207. PubMed ID: 26085216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
